Proteomic analysis of ceftazidime and meropenem-exposed Pseudomonas aeruginosa ATCC 9027

Hong Loan Ngo1,2, Thuc Quyen Huynh1,2,3, Nguyen Bao Vy Tran1,2

  • 1School of Biotechnology, International University, Ho Chi Minh City, Vietnam.

Proteome Science
|September 28, 2023
PubMed
Abstract

Insights

Pseudomonas aeruginosa proteomic responses to ceftazidime (Caz) and meropenem (Mem) revealed significant changes in antibiotic resistance and virulence proteins. Understanding these changes is crucial for developing effective anti-pseudomonas therapies.

Area of Science:

  • Microbiology
  • Proteomics
  • Drug Discovery

Background:

  • Pseudomonas aeruginosa exhibits intrinsic antibiotic resistance, complicating treatment strategies.
  • Understanding the pathogen's proteomic response to antibiotics is vital for developing novel therapeutic approaches.

Purpose of the Study:

  • To investigate the proteomic response of P. aeruginosa to ceftazidime (Caz) and meropenem (Mem).
  • To identify differentially expressed proteins (DEPs) involved in antibiotic resistance and virulence.

Main Methods:

  • Antibiotic-susceptible P. aeruginosa ATCC 9027 was exposed to sub-inhibitory concentrations of Caz or Mem for 14 days.
  • Proteomic analysis using isobaric tags for relative and absolute quantitation (iTRAQ) and nano LC-MS/MS.
  • Quantitative reverse transcriptase PCR (qRT-PCR) was used to validate protein expression changes.

Main Results:

  • Exposure to Caz and Mem resulted in approximately 10% changes in the P. aeruginosa proteome.
  • Key proteins involved in antibiotic resistance (e.g., AmpC) were upregulated, while those in protein synthesis and metabolic processes were downregulated.
  • Specific proteins like OprD, TssC1, Hcp1, Azu, and PagL showed altered expression patterns in response to Caz and Mem.

Conclusions:

  • Sub-MIC exposure to Caz and Mem induces significant proteomic alterations in P. aeruginosa, affecting both antibiotic resistance and virulence.
  • Both antibiotics led to AmpC upregulation and OprD downregulation, suggesting a common resistance mechanism.
  • Distinct protein changes were observed for Caz (TssC1, Hcp1) and Mem (Azu, PagL) responses, highlighting drug-specific adaptations.